Efficacy and Safety of Torcetrapib, a Novel Cholesteryl Ester Transfer Protein Inhibitor, in Individuals With Below-Average High-Density Lipoprotein Cholesterol Levels
Author:
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine
Reference22 articles.
1. Benefit-risk assessment of rosuvastatin 10 to 40 milligrams;Brewer;Am J Cardiol,2003
2. Fibrates in 2003: therapeutic action in atherogenic dyslipidaemia and future perspectives;Chapman;Atherosclerosis,2003
3. Raising high-density lipoprotein cholesterol with reduction of cardiovascular risk: the role of nicotinic acid—a position paper developed by the European Consensus Panel on HDL-C;Chapman;Curr Med Res Opin,2004
4. Cholesteryl ester transfer protein: a novel target for raising HDL and inhibiting atherosclerosis;Barter;Arterioscler Thromb Vasc Biol,2003
5. Heterogeneity of plasma low-density lipoproteins and atherosclerosis risk;Krauss;Curr Opin Lipidol,1994
Cited by 121 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Major Causes Associated with Clinical Trials Failure and Selective Strategies to Reduce these Consequences: A Review;Archives Of Pharmacy Practice;2021
2. Learning by experience;Principles of Translational Science in Medicine;2021
3. Evacetrapib reduces preβ-1 HDL in patients with atherosclerotic cardiovascular disease or diabetes;Atherosclerosis;2019-06
4. Safety in Early Phase Studies;Statistical Methods in Biomarker and Early Clinical Development;2019
5. From lipid locus to drug target through human genomics;Cardiovascular Research;2018-05-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3